Retail sale of pharmaceutical products
PETTERSEN INVEST AS
Revenue 2025
NOK −41,000
Operating profit
NOK −202,000
Equity
NOK 13.1m
Incorporated
2005
Share capital
NOK 150,000
Key figures · 2025
Current ratio
25.78
Equity ratio
97.6%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 490.2% | |
| Net margin (%%) | -4333.0% | |
| Return on assets (%%) | -1.5% | |
| Likviditet | ||
| Current ratio | 25.78 | |
| Working capital | 8.1m | |
| Soliditet | ||
| Equity ratio (%%) | 97.6% | |
| Debt-to-equity ratio | 0.02 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.